5 Unstoppable Stocks That Could Double Your Money

4. Cyclerion Therapeutics Inc. (NASDAQ:CYCN)

Cyclerion Therapeutics Inc. (NASDAQ:CYCN) is one of the unstoppable stocks that could double your money. On April 1, Cyclerion and Korsana Biosciences entered into a definitive merger agreement to form a combined entity operating under the name Korsana Biosciences, trading under the ticker ‘KRSA’. The merger aims to advance Korsana’s neurodegenerative disease pipeline, headlined by KRSA-028, a next-gen antibody targeting amyloid beta for Alzheimer’s disease.

This lead program uses the proprietary THETA platform, which is designed to improve brain delivery and safety while offering the convenience of subcutaneous administration. In conjunction with the merger, Korsana secured $380 million in private financing from a syndicate of leading healthcare investors, including Fairmount and Venrock Healthcare Capital Partners. This capital is expected to fund operations into 2029, providing the necessary runway to reach critical clinical milestones.

Key upcoming data readouts include Phase 1 healthy volunteer results in mid-2027 and interim proof-of-concept data regarding amyloid plaque clearance in Alzheimer’s patients by the end of 2027. The transaction follows a review by Cyclerion Therapeutics Inc. (NASDAQ:CYCN) and represents an opportunity to use Korsana’s innovative platform, which was developed in partnership with Paragon Therapeutics.

Cyclerion Therapeutics Inc. (NASDAQ:CYCN) is a biotech company that deals with serious diseases with novel sGC stimulators in the CNS and the periphery. The company is licensed by Akebia to develop Praliciguat and related products, including medical affairs.